EuroFlow: Resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine.
作者信息
van Dongen J J M, Orfao A
出版信息
Leukemia. 2012 Sep;26(9):1899-907. doi: 10.1038/leu.2012.121.
Abstract
摘要
相似文献
1
EuroFlow: Resetting leukemia and lymphoma immunophenotyping. Basis for companion diagnostics and personalized medicine.
Leukemia. 2012 Sep;26(9):1899-907. doi: 10.1038/leu.2012.121.
2
Improved detection of CD2 on formaldehyde-fixed non dehydrated cells.
Nouv Rev Fr Hematol (1978). 1995;37(6):385.
3
Detection of intracellular/intranuclear antigens. Applications in leukemia/lymphoma analysis.
Methods Mol Biol. 1998;91:47-55. doi: 10.1385/0-89603-354-6:47.
4
Establishment of harmonization in immunophenotyping: A comparative study of a standardized one-tube lymphocyte-screening panel.
Cytometry B Clin Cytom. 2014 Nov;86(6):418-25. doi: 10.1002/cytob.21158.
5
The usefulness of immunophenotypic and genotypic studies in the diagnosis and classification of hematopoietic and lymphoid neoplasms. An update.
Am J Clin Pathol. 1999 Jan;111(1 Suppl 1):S13-39.
6
U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: selection of antibody combinations.
Cytometry. 1997 Oct 15;30(5):231-5. doi: 10.1002/(sici)1097-0320(19971015)30:5<231::aid-cyto3>3.0.co;2-k.
7
Flow-cytometric analysis of lymphocytes, leukaemias and lymphomas.
Br J Biomed Sci. 1993 Dec;50(4):334-49.
8
Expression of CDw12 and CD17 cell surface antigens on leukemic cells from patients with blood malignancies.
Folia Biol (Praha). 1993;39(3):124-8.
9
Use of flow cytometric immunophenotyping to refine the cytological diagnosis of canine lymphoma.
Vet J. 2011 May;188(2):149-55. doi: 10.1016/j.tvjl.2010.03.011. Epub 2010 Apr 21.
10
Nonendemic adult T-cell leukemia/lymphoma.
Hum Pathol. 1982 Aug;13(8):691-3. doi: 10.1016/s0046-8177(82)80290-6.
引用本文的文献
1
World Health Organization (WHO)'s vision for a leukemia-free Africa: opportunities and challenges- a narrative review.
Ann Med Surg (Lond). 2025 Jul 11;87(9):5661-5677. doi: 10.1097/MS9.0000000000003553. eCollection 2025 Sep.
2
Advancing Leukemia Diagnosis and Treatment: WHO-Supported Laboratory Innovations in Africa- A Narrative Review.
Blood Lymphat Cancer. 2025 Jun 24;15:47-67. doi: 10.2147/BLCTT.S518005. eCollection 2025.
3
Prognostic implications of CD9 in childhood acute lymphoblastic leukemia: insights from a nationwide multicenter study in China.
Leukemia. 2024 Feb;38(2):250-257. doi: 10.1038/s41375-023-02089-3. Epub 2023 Nov 25.
4
Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged acute lymphoblastic leukemia.
Exp Hematol Oncol. 2023 Sep 22;12(1):81. doi: 10.1186/s40164-023-00445-8.
5
Immunophenotypic characterization of acute leukemias in Bahia, Brazil.
Einstein (Sao Paulo). 2023 Jan 6;21:eAO0117. doi: 10.31744/einstein_journal/2023AO0117. eCollection 2023.
6
"Friends and foes" of multiple myeloma measurable/minimal residual disease evaluation by next generation flow.
Front Oncol. 2022 Nov 28;12:1057713. doi: 10.3389/fonc.2022.1057713. eCollection 2022.
7
Diagnostic challenges in acute monoblastic/monocytic leukemia in children.
Front Pediatr. 2022 Sep 28;10:911093. doi: 10.3389/fped.2022.911093. eCollection 2022.
8
Evaluation of fixed-panel, multicolour ClearLLab 10C at an academic flow cytometry laboratory in Johannesburg, South Africa.
Afr J Lab Med. 2022 Jul 15;11(1):1458. doi: 10.4102/ajlm.v11i1.1458. eCollection 2022.
9
Flow Cytometry Immunophenotyping for Diagnostic Orientation and Classification of Pediatric Cancer Based on the EuroFlow Solid Tumor Orientation Tube (STOT).
Cancers (Basel). 2021 Sep 30;13(19):4945. doi: 10.3390/cancers13194945.
10
Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts.
J Immunother Cancer. 2021 Jun;9(6). doi: 10.1136/jitc-2020-001514.
本文引用的文献
1
EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols.
Leukemia. 2012 Sep;26(9):1986-2010. doi: 10.1038/leu.2012.122.
2
Flow cytometric immunobead assay for fast and easy detection of PML-RARA fusion proteins for the diagnosis of acute promyelocytic leukemia.
Leukemia. 2012 Sep;26(9):1976-85. doi: 10.1038/leu.2012.125. Epub 2012 May 8.
3
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes.
Leukemia. 2012 Sep;26(9):1908-75. doi: 10.1038/leu.2012.120. Epub 2012 May 3.
4
Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work Package 10.
Leukemia. 2011 Apr;25(4):567-74. doi: 10.1038/leu.2010.312. Epub 2011 Jan 21.
5
Detection of fusion genes at the protein level in leukemia patients via the flow cytometric immunobead assay.
Best Pract Res Clin Haematol. 2010 Sep;23(3):333-45. doi: 10.1016/j.beha.2010.09.010. Epub 2010 Nov 3.
6
Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping.
Leukemia. 2010 Nov;24(11):1927-33. doi: 10.1038/leu.2010.160. Epub 2010 Sep 16.
7
Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell-related disorders.
Cytometry B Clin Cytom. 2010 Jul;78(4):239-52. doi: 10.1002/cyto.b.20512.
8
Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes.
Haematologica. 2009 Aug;94(8):1124-34. doi: 10.3324/haematol.2009.005801. Epub 2009 Jun 22.
9
Flow cytometric immunobead assay for the detection of BCR-ABL fusion proteins in leukemia patients.
Leukemia. 2009 Jun;23(6):1106-17. doi: 10.1038/leu.2009.93. Epub 2009 Apr 23.
10
CD200 expression may help in differential diagnosis between mantle cell lymphoma and B-cell chronic lymphocytic leukemia.
Leuk Res. 2009 Sep;33(9):1212-6. doi: 10.1016/j.leukres.2009.01.017. Epub 2009 Feb 20.
Zotero 插件